Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren in Elderly Patients With Essential Hypertension
NCT00706134Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of aliskiren in essential hypertension, sponsored by Novartis. Started May 2008; status: completed.
02
Drugs
aliskiren
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00706134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00706134.